Nordic Capital invests in CRO and CDMO Minerva Imaging

Minerva specializes in the development of targeted radioligand therapies.

11 June 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.